Digest Network Come funziona
Network
/
Società
Am
Non verificato

Amylyx Pharmaceuticals, Inc.

Di cosa scriviamo

BiotecnologiaFarmaceuticaMedicina - VarieSaluteWeb e Social Network

56 comunicati stampa

Guarda tutti i comunicati
23/06/2026
Eventi
Industria
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Amylyx Pharmaceuticals to Present Data from First-in-Human, Dose-Ranging Phase 1 LUMINA Trial of AMX0114 in ALS at ENCALS 2026
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
08/06/2026
Salute
Igiene alimentare
Biologia
Medicina - Varie
Farmaceutica
Biotecnologia
Eventi
Fiere
Amylyx Pharmaceuticals Announces Poster Presentations at ENDO 2026
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
15/05/2026
Analisi di mercato
Industria
Scienza
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Sanità
Amylyx Pharmaceuticals Announces Peer-Reviewed Publication of Phase 2 Open-Label HELIOS Trial Data for AMX0035 in The Journal of Clinical Investigation
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
07/05/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Salute
Medicina - Varie
Farmaceutica
Biotecnologia
Amylyx Pharmaceuticals Reports First Quarter 2026 Financial Results
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
06/05/2026
Eventi
Web e Social Network
Biotecnologia
Farmaceutica
Salute
Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
05/05/2026
Industria
Salute
Sanità
Medicina - Varie
Farmaceutica
Amylyx Pharmaceuticals Announces U.S. Expanded Access Program for Adults with Post-Bariatric Hypoglycemia
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
30/04/2026
Web e Social Network
Telefonia e Varie
Finanza
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Amylyx Pharmaceuticals to Report First Quarter 2026 Financial Results on May 7, 2026
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
08/04/2026
Web e Social Network
Fiere
Eventi
Salute
HIV, AIDS e malattie autoimmuni
Sanità
Farmaceutica
Biotecnologia
Amylyx Pharmaceuticals to Present at the 25th Annual Needham Virtual Healthcare Conference
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
24/03/2026
Industria
Biotecnologia
Farmaceutica
Sanità
Medicina - Varie
Salute
Fitness
Amylyx Pharmaceuticals Announces Completion of Enrollment in Pivotal Phase 3 LUCIDITY Clinical Trial of Avexitide in Post-Bariatric Hypoglycemia
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0
03/03/2026
Web e Social Network
Telefonia e Varie
Mercato azionario
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results
Fonte
Amylyx Pharmaceuticals, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0